Financial Ratios

STERLING BIOTECH LTD.

NSE : STERLINBIOBSE : 512299ISIN CODE : INE324C01038Industry : ChemicalsHouse : Sandesara
BSE0.770 (0 %)
PREV CLOSE ( ) 0.77
OPEN PRICE ( ) 0.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.77 (38071)
VOLUME 45051
TODAY'S LOW / HIGH ( )0.77 0.85
52 WK LOW / HIGH ( )0.77 0.85
NSE0.700 (0 %)
PREV CLOSE( ) 0.70
OPEN PRICE ( ) 0.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16887
TODAY'S LOW / HIGH( ) 0.65 0.75
52 WK LOW / HIGH ( )0.65 0.75
Select year
ParticularsMar2024Mar2023Mar2022Mar2018Mar2017
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.039.31-10.85-36.94-15.15
   CEPS(Rs)-0.019.55-1.93-27.91-5.47
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)1.371.40-210.6210.1446.89
   Tax Rate(%)-178.123.90-1.8330.0933.13
Margin Ratios
   Core EBITDA Margin(%)14.4913.53-12.073.923.14
   EBIT Margin(%)-1.361435.11-70.23-277.56-61.72
   Pre Tax Margin(%)-1.521435.06-70.73-399.78-154.13
   PAT Margin (%)-4.221379.08-72.03-279.49-103.06
   Cash Profit Margin (%)-0.881415.51-12.78-211.17-37.21
Performance Ratios
   ROA(%)-3.07477.82-6.60-13.37-5.11
   ROE(%)-2.170.000.00-129.56-28.06
   ROCE(%)-0.70385.79-5.70-12.49-3.00
   Asset Turnover(x)0.730.350.090.050.05
   Sales/Fixed Asset(x)0.560.210.120.110.12
   Working Capital/Sales(x)1.311.49-0.41-0.07-0.20
Efficiency Ratios
   Fixed Capital/Sales(x)1.794.738.059.158.21
   Receivable days41.0136.0938.8448.0339.03
   Inventory Days87.1379.0268.28387.72647.95
   Payable days58.3146.7142.7942.5240.20
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.00-0.06-0.79
   Price/Book(x)0.000.000.000.160.09
   Yield(%)0.000.00
   EV/Net Sales(x)0.991.1019.2621.3619.13
   EV/Core EBITDA(x)5.256.95-175.33383.95425.92
   EV/EBIT(x)-72.650.08-27.42-7.54-28.54
   EV/CE(x)0.510.533.381.070.88
   M Cap / Sales0.000.000.000.130.32
Growth Ratio
   Net Sales Growth(%)5.205.9516.33-4.37-29.69
   Core EBITDA Growth(%)25.02252.87-329.7318.41-77.11
   EBIT Growth(%)-100.102264.9671.17-304.239.47
   PAT Growth(%)-100.322128.4970.64-143.768.44
   EPS Growth(%)-100.32185.8270.64-143.768.44
Financial Stability Ratios
   Total Debt/Equity(x)0.010.00-1.4127.165.45
   Current Ratio(x)7.7210.970.260.090.35
   Quick Ratio(x)5.367.700.190.070.12
   Interest Cover(x)-8.680.00-139.69-2.27-0.67
   Total Debt/Mcap(x)165.8459.38

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.